French ccAFU guidelines update 2020-2022: penile cancer

被引:0
|
作者
Savoie, P-H [1 ,2 ]
Morel-Journel, N. [1 ,3 ]
Murez, T. [1 ,4 ]
Ferretti, L. [1 ,5 ]
Rocher, L. [1 ,6 ,7 ]
Flechon, A. [1 ,8 ]
Camparo, P. [1 ,9 ]
Mejean, A. [1 ,10 ]
机构
[1] Assoc Francaise Urol, Com Ccancerol, Grp Organes Genitaux Externes, Maison Urol, 11 Rue Viete, F-75017 Paris, France
[2] Hop Instruct Armees St Anne, Serv Chirurg Urol, 2 Blvd St Anne,BP 600, F-83800 Toulon 09, France
[3] CHU Lyon, Serv Urol, 165 Chemin Grand Revoyet, F-69310 Pierre Benite, France
[4] CHU Montpellier, Serv Urol & Transplantat Renale, 371 Ave Doyen Gaston Giraud, F-34295 Montpellier 5, France
[5] MSP Bordeaux Bagatelle, 203 Route Toulouse, F-33401 Talence, France
[6] Hop Antoine Beclere, AP HP, Serv Radiol, 157 Rue Porte Trivaux, F-92140 Clamart, France
[7] Univ Paris Saclay, BIOMAPS, 63 Ave Gabriel Peri, F-94270 Le Kremlin Bicetre, France
[8] Ctr Leon Berard, 28 Rue Laennec, F-69008 Lyon, France
[9] Inst Pathol Hauts de France, 51 Rue Jeanne dArc, F-80000 Amiens, France
[10] Hop Europeen Georges Pompidou, AP HP, Serv Urol & Transplantat Renale, 20 Rue Leblanc, F-75015 Paris, France
来源
PROGRES EN UROLOGIE | 2020年 / 30卷 / 12期
关键词
Epidermoid carcinoma; Penile cancer; Inguinat adenopathy; Penectomy; Lymphadenectomy; SQUAMOUS-CELL CARCINOMA; INGUINAL LYMPH-NODE; HUMAN-PAPILLOMAVIRUS; NEOADJUVANT CHEMOTHERAPY; SURGICAL-MANAGEMENT; TNM CLASSIFICATION; PHASE-II; CISPLATIN; LYMPHADENECTOMY; BLEOMYCIN;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective. - To update French oncology guidelines concerning penile cancer. Methods. - Comprehensive Medline search between 2018 and 2020 upon diagnosis, treatment and follow-up of testicular germ cell cancer to update previous guidelines. Level of evidence was evaluated according to AGREE-II. Results. - Epidermoid carcinoma is the most common penile cancer histology. Physical examination is mandatory to define local and inguinal nodal cancer stage. MRI with artificial erection can help to assess deep infiltration in cases of organsparing intention. Node negative patients (defined by palpation and imaging) will present micro nodal metastases in up to 25% of cases. Invasive lymph node assessment is thus advocated except for low risk patients. Sentinel node dynamic biopsy is the first line technique. Modified bilateral inguinal lymphadenectomy is an option with higher morbidity. 18-FDG-PET is recommended in patients with palpable nodes. Chest, abdominal and pelvis computerized tomography is an option. Fine needle aspiration (when positive) is an easy way to assess inguinal palpable node pathological involvement. Its results determine the type of lymphadenectomy to be performed (for diagnostic or curative purposes). Treatment is mostly surgical. Free margins status is essential, but it also has to be organ-sparing when possible. Brachytherapy and topic agents can cure in selected cases. Lymph node assessment should be synchronous to the removal of the tumour when possible. Limited inguinal lymph node involvement (pN1 stage) can be cured with the only lymphadenectomy. In case of larger lymph node stage, one should consider multidisciplinary treatment including chemotherapy and inclusion in a trial. Conclusions. - Penile cancer needs demanding surgery to be cured, surrounded by chemotherapy in node positive patients. Lymph nodes involvement is a major prognostic factor. Thus, inguinal node assessment cannot be neglected. (C) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:S252 / S279
页数:28
相关论文
共 50 条
  • [1] French ccAFU guidelines - update 2020-2022: prostate cancer
    Rozet, F.
    Mongiat-Artus, P.
    Hennequin, C.
    Beauval, J. B.
    Beuzeboc, P.
    Cormier, L.
    Fromont-Hankard, G.
    Mathieu, R.
    Ploussard, G.
    Renard-Penna, R.
    Brenot-Rossi, I
    Bruyere, F.
    Cochet, A.
    Crehange, G.
    Cussenot, O.
    Lebret, T.
    Rebillard, X.
    Soulie, M.
    Brureau, L.
    Mejean, A.
    PROGRES EN UROLOGIE, 2020, 30 (12): : S136 - S251
  • [2] French ccAFU guidelines - update 2020-2022: bladder cancer
    Roupret, M.
    Pignot, G.
    Masson-Lecomte, A.
    Comperat, E.
    Audenet, F.
    Roumiguie, M.
    Houede, N.
    Larre, S.
    Brunelle, S.
    Xylinas, E.
    Neuzillet, Y.
    Mejean, A.
    PROGRES EN UROLOGIE, 2020, 30 (12): : S78 - S135
  • [3] Update 2020-2022 of French ccAFU guidelines - Editorial
    Mejean, A.
    PROGRES EN UROLOGIE, 2020, 30 (12): : S1 - S1
  • [4] French ccAFU guidelines - update 2020-2022: management of kidney cancer
    Bensalah, K.
    Albiges, L.
    Bernhard, J-C
    Bigot, P.
    Bodin, T.
    Boissier, R.
    Correas, J-M
    Gimel, P.
    Hetet, J-F
    Long, J-A
    Nouhaud, F-X
    Ouzaid, I
    Rioux-Leclercq, N.
    Mejean, A.
    PROGRES EN UROLOGIE, 2020, 30 (12): : S2 - S51
  • [5] French ccAFU guidelines - update 2020-2022: retroperitoneal sarcoma
    Murez, T.
    Savoie, P-H
    Flechon, A.
    Rocher, L.
    Camparo, P.
    Morel-Journel, N.
    Ferretti, L.
    Mejean, A.
    PROGRES EN UROLOGIE, 2020, 30 (12): : S314 - S330
  • [6] French ccAFU guidelines - update 2020-2022: malignancy assessment of an adrenal incidentaloma
    Savoie, P-H
    Murez, T.
    Flechon, A.
    Rocher, L.
    Ferretti, L.
    Morel-Journel, N.
    Camparo, P.
    Mejean, A.
    PROGRES EN UROLOGIE, 2020, 30 (12): : S331 - S352
  • [7] French ccAFU guidelines - update 2020-2022: testicular germ cell tumors
    Murez, T.
    Flechon, A.
    Savoie, P-H
    Rocher, L.
    Camparo, P.
    Morel-Journel, N.
    Ferretti, L.
    Mejean, A.
    PROGRES EN UROLOGIE, 2020, 30 (12): : S280 - S313
  • [8] French ccAFU guidelines - Update 2018-2020: Penile cancer
    Savoie, P. -H.
    Flechon, A.
    Morel-Journel, N.
    Murez, T.
    Ferretti, L.
    Camparo, P.
    Rocher, L.
    Sebe, P.
    Mejean, A.
    PROGRES EN UROLOGIE, 2018, 28 : R133 - R148
  • [9] French ccAFU guidelines - update 2020-2022: upper urinary tract urothelial carcinoma
    Roupret, M.
    Audenet, F.
    Roumiguie, M.
    Pignot, G.
    Masson-Lecomte, A.
    Comperat, E.
    Houede, N.
    Larre, S.
    Brunelle, S.
    Xylinas, E.
    Neuzillet, Y.
    Mejean, A.
    PROGRES EN UROLOGIE, 2020, 30 (12): : S52 - S77
  • [10] French ccAFU guidelines-update 2020-2022: Prostate cancer (vol 30, pg S136, 2020)
    Rozet, F.
    Mongiat-Artus, P.
    Hennequin, C.
    Beauval, J. B.
    Beuzeboc, P.
    Cormier, L.
    Fromont-Hankard, G.
    Mathieu, R.
    Ploussard, G.
    Renard-Penna, R.
    Brenot-Rossi, I.
    Bruyere, F.
    Cochet, A.
    Crehange, G.
    Cussenot, O.
    Lebret, T.
    Rebillard, X.
    Soulie, M.
    Brureau, L.
    Mejean, A.
    PROGRES EN UROLOGIE, 2021, 31 (06): : 381 - 382